Understanding the genetic basis of hereditary diffuse gastric cancer

Gastric cancer, a significant global health burden, claims over 7% of cancer-related deaths annually. Although only 1-3% of cases have a genetic basis, understanding these genetic drivers is crucial for developing preventative strategies.

At ASCO: big readouts, revenue questions, and the ups and downs of ADCs

CHICAGO – More than 40,000 clinicians, biopharma executives, investors, drug salespeople and many others involved in cancer research descended upon McCormick Place in Chicago for

June 4, 2024

Uppsala and KTH Royal develop antibody for potential cancer treatment

The solution was tested on both mice and human blood. Credit: THICHA SATAPITANON via Shutterstock. A team of researchers from Uppsala University and KTH Royal

November 12, 2024

UArizona researcher awarded $1.3 million to study lifestyle interventions in American Indian cancer patients

A University of Arizona Cancer Center researcher was awarded a $1.3 million grant from the National Cancer Institute to study the effectiveness of lifestyle interventions

July 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.